Tetanus Antibody Detection in Saliva Study
Part of Infections clinical trials.
This study looks at how well a tetanus booster vaccine works by testing your saliva and blood. It includes healthy children, young adults, pregnant women, and adults with certain medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must be healthy and in one of these age groups: 5-10, 18-25, or you could be a pregnant woman before getting a tetanus booster, or an adult 18-45 with a medical condition that might affect vaccine response.
- You must be willing to give a small blood and saliva sample for the study.
- You cannot have a bleeding disorder that makes blood draws risky.
- If you are not in the medical condition group (Group D), you cannot have any other health problem that could affect your immune system or make a blood draw unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
This trial tests a new injection (SNA02-48) designed to protect adults who are at high risk of tetanus infection. Tetanus is a serious bacterial infection that can cause severe muscle stiffness and life-threatening complications; this study evaluates whether this new protective treatment is safe and effective.
This study tests a new type of patch with tiny needles (microneedles) that delivers a tetanus vaccine booster through your skin instead of a traditional injection. Researchers want to confirm it's safe and works well in healthy adults.
This study compares a new tetanus shot (siltartoxatug) with standard tetanus treatments to see if it works as well. It is for people aged 18 and older who need tetanus protection after an injury.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
This trial tests a new combination vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and helps the body build immunity.
Hear when a new Tetanus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.